Event Title Go back to Home Page
Event Summary  
Event Type Medicine - Misbranded/Mislabeled
Medicine - Pharmaceutical Recalls 
Date Time 2019-02-04 23:10:00 
Country IN  City Hyderabad, TS 
Latitude 17.385  Longitude 78.487 
URL https://www.apnews.com/43bacc9a3cbc4b23b5572353734bc556     
[apnews.com] INDIA - Dr Reddys Laboratories Continues Its Voluntary Nationwide Recall Of Levetiracetam In 0 Point 54 Percent Sodium Chloride Injection 1500mg Or 100mL Due to Mislabeling

"Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that its wholly owned subsidiary, Dr Reddy’s Laboratories, Inc, is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A."

Read the full article:



Copyright © 2006-2012  All Rights Reserved.